{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T02:57:47Z","timestamp":1773025067345,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T00:00:00Z","timestamp":1624752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T00:00:00Z","timestamp":1624752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010816","name":"Anhui Science and Technology Department","doi-asserted-by":"publisher","award":["No. KJ2019A0404"],"award-info":[{"award-number":["No. KJ2019A0404"]}],"id":[{"id":"10.13039\/501100010816","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010816","name":"Anhui Science and Technology Department","doi-asserted-by":"publisher","award":["No. KJ2019A0405"],"award-info":[{"award-number":["No. KJ2019A0405"]}],"id":[{"id":"10.13039\/501100010816","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81874280"],"award-info":[{"award-number":["No. 81874280"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81673266"],"award-info":[{"award-number":["No. 81673266"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Fifth Batch of Talents Selected under the Special Support Plan in Anhui Provence","award":["[2019]No.14"],"award-info":[{"award-number":["[2019]No.14"]}]},{"DOI":"10.13039\/501100009558","name":"University Natural Science Research Project of Anhui Province","doi-asserted-by":"publisher","award":["No. 1808085QH283"],"award-info":[{"award-number":["No. 1808085QH283"]}],"id":[{"id":"10.13039\/501100009558","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009558","name":"University Natural Science Research Project of Anhui Province","doi-asserted-by":"publisher","award":["No. 1808085MH297"],"award-info":[{"award-number":["No. 1808085MH297"]}],"id":[{"id":"10.13039\/501100009558","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hypertension and overweight are independent risk factors for cardiovascular disease, and overweight increase the risk of developing high blood pressure. ERBB3( also known as HER3) plays a considerable role in the development of cardiovascular diseases. However, the effect of ERBB3 levels in hypertensive overweight patients is unknown. The aim of this study was to assess the association between ERBB3 levels and hypertension in overweight Chinese patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We evaluated the height,weight, blood pressure, biochemical indicators, and ERBB3 levels in 128 Chinese adults aged 33\u201379 years. Plasma ERBB3 levels were assessed by the enzyme-linked immunosorbent assay, and body mass index(BMI) was calculated as body weight divided by height squared. Participants were allocated into three groups according to blood pressure and BMI: healthy control (CNT, <jats:italic>n<\/jats:italic>\u2009=\u200931; normotensive and non-overweight), hypertension (HT, <jats:italic>n<\/jats:italic>\u2009=\u200933; hypertension and non-overweight), and hypertension with overweight (HTO, <jats:italic>n<\/jats:italic>\u2009=\u200964; hypertension and overweight). Statistical significance was defined as a two-tailed <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There was no significant difference in mean ERBB3 levels among the three groups, although a linear decrease from CNT (1.13\u2009\u00b1\u20090.36), HT (1.03\u2009\u00b1\u20090.36), to HTO (0.84\u2009\u00b1\u20090.26 ng\/mL) was observed in men (<jats:italic>P<\/jats:italic>\u2009=\u20090.007). Among the drinking population, the ERBB3 level was significantly reduced in the HTO group as compared with those of the CNT and HT groups (0.76\u2009\u00b1\u20090.23 versus 1.18\u2009\u00b1\u20090.37 and 1.20\u2009\u00b1\u20090.30, respectively). ERBB3 levels were negatively correlated with diastolic blood pressure in men (<jats:italic>r<\/jats:italic>= \u2212\u20090.293, <jats:italic>P<\/jats:italic>\u2009=\u20090.012), smoking (<jats:italic>r<\/jats:italic>= \u2212\u20090.47, <jats:italic>P<\/jats:italic>\u2009=\u20090.004), and drinking (<jats:italic>r<\/jats:italic> = \u2212\u20090.387, <jats:italic>P<\/jats:italic>\u2009=\u20090.008). BMI in men and among drinkers, and uric acid among drinkers were negatively correlated with ERBB3 levels. Multivariate conditional logistic regression showed that plasma ERBB3 levels were associated with a reduced risk of HTO in men [odds ratio (OR) 0.054; 95\u2009% confidence interval (<jats:italic>CI)<\/jats:italic>: 0.007\u20130.412) and drinkers (<jats:italic>OR<\/jats:italic> 0.002; 95\u2009% <jats:italic>CI<\/jats:italic>: 0.000\u20130.101).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>ERBB3 may contribute to the pathogenesis of hypertension in overweight patients, with BMI, gender, and drinking all potentially modulating the process.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12902-021-00793-8","type":"journal-article","created":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T13:02:27Z","timestamp":1624798947000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Circulating ERBB3 levels are inversely associated with the risk of overweight-related hypertension: a cross-sectional study"],"prefix":"10.1186","volume":"21","author":[{"given":"Lijun","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengmei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuelong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengyun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingshui","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,27]]},"reference":[{"key":"793_CR1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1001\/jamainternmed.2016.0190","volume":"176","author":"S Lewington","year":"2016","unstructured":"Lewington S, Lacey B, Clarke R, Guo Y, Kong XL, Yang L, Chen Y, Bian Z, Chen J, Meng J, Xiong Y, He T, Pang Z, Zhang S, Collins R, Peto R, Li L, Chen Z. China Kadoorie Biobank C. (2016) The Burden of Hypertension and Associated Risk for Cardiovascular Mortality in China. JAMA Intern Med 176:524\u201332. https:\/\/doi.org\/10.1001\/jamainternmed.2016.0190.","journal-title":"JAMA Intern Med"},{"key":"793_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0140-6736(16)31919-5","volume":"389","author":"NCDRF Collaboration","year":"2017","unstructured":"Collaboration NCDRF. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet. 2017;389:37\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(16)31919-5.","journal-title":"Lancet"},{"key":"793_CR3","first-page":"209","volume":"34","author":"ST Hu","year":"2019","unstructured":"Hu ST, Gao RL, Liu LS, Zhu ML, Wang W, Wang YJ, Wu ZS, Li HJ, Gu DF, Yang YJ, Zheng Z, Cheng WW. Summary of report on cardiovascular diseases in China (2018). Chin Circ J. 2019;34:209\u201320.","journal-title":"Chin Circ J"},{"key":"793_CR4","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1161\/HYPERTENSIONAHA.108.113357","volume":"52","author":"JA Cutler","year":"2008","unstructured":"Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988\u20131994 and 1999\u20132004. Hypertension. 2008;52:818\u201327. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.108.113357.","journal-title":"Hypertension"},{"key":"793_CR5","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1001\/archinte.162.16.1867","volume":"162","author":"PW Wilson","year":"2002","unstructured":"Wilson PW, D\u2019Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002;162:1867\u201372. https:\/\/doi.org\/10.1001\/archinte.162.16.1867.","journal-title":"Arch Intern Med"},{"key":"793_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1440-1754.2011.02221.x","volume":"48","author":"J Ma","year":"2012","unstructured":"Ma J, Wang Z, Dong B, Song Y, Hu P, Zhang B. Quantifying the relationships of blood pressure with weight, height and body mass index in Chinese children and adolescents. J Paediatr Child Health. 2012;48:413\u20138. https:\/\/doi.org\/10.1111\/j.1440-1754.2011.02221.x.","journal-title":"J Paediatr Child Health"},{"key":"793_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2188\/jea.je20110120","volume":"22","author":"RN Feng","year":"2012","unstructured":"Feng RN, Zhao C, Wang C, Niu YC, Li K, Guo FC, Li ST, Sun CH, Li Y. BMI is strongly associated with hypertension, and waist circumference is strongly associated with type 2 diabetes and dyslipidemia, in northern Chinese adults. J Epidemiol. 2012;22:317\u201323. https:\/\/doi.org\/10.2188\/jea.je20110120.","journal-title":"J Epidemiol"},{"key":"793_CR8","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/HJH.0000000000000807","volume":"34","author":"C Linhart","year":"2016","unstructured":"Linhart C, Tukana I, Lin S, Taylor R, Morrell S, Vatucawaqa P, Magliano D, Zimmet P. Continued increases in hypertension over three decades in Fiji, and the influence of obesity. J Hypertens. 2016;34:402\u20139. https:\/\/doi.org\/10.1097\/HJH.0000000000000807. discussion 409.","journal-title":"J Hypertens"},{"key":"793_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/35052073","volume":"2","author":"Y Yarden","year":"2001","unstructured":"Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol. 2001;2:127\u201337. https:\/\/doi.org\/10.1038\/35052073.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"793_CR10","doi-asserted-by":"publisher","first-page":"7692","DOI":"10.1073\/pnas.1002753107","volume":"107","author":"F Shi","year":"2010","unstructured":"Shi F, Telesco SE, Liu Y, Radhakrishnan R, Lemmon MA. Erbb3\/her3 intracellular domain is competent to bind atp and catalyze autophosphorylation. Proc Natl Acad Sci U S A. 2010;107:7692\u20137. https:\/\/doi.org\/10.1073\/pnas.1002753107.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"793_CR11","doi-asserted-by":"publisher","first-page":"4899","DOI":"10.2174\/1381612819666131125151058","volume":"20","author":"N Hedhli","year":"2014","unstructured":"Hedhli N, Kalinowski A and Russell KS. Cardiovascular effects of neuregulin-1\/ErbB signaling: role in vascular signaling and angiogenesis. Curr Pharm Des. 2014;20:4899\u2013905. https:\/\/doi.org\/10.2174\/1381612819666131125151058.","journal-title":"Curr Pharm Des"},{"key":"793_CR12","doi-asserted-by":"publisher","first-page":"H907","DOI":"10.1152\/ajpheart.00486.2016","volume":"312","author":"S Ryzhov","year":"2017","unstructured":"Ryzhov S, Matafonov A, Galindo CL, Zhang Q, Tran TL, Lenihan DJ, Lenneman CG, Feoktistov I, Sawyer DB. ERBB signaling attenuates proinflammatory activation of nonclassical monocytes. Am J Physiol Heart Circ Physiol. 2017;312:H907\u201318. https:\/\/doi.org\/10.1152\/ajpheart.00486.2016.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"793_CR13","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1038\/nm.3713","volume":"20","author":"GX Wang","year":"2014","unstructured":"Wang GX, Zhao XY, Meng ZX, Kern M, Dietrich A, Chen Z, Cozacov Z, Zhou D, Okunade AL, Su X, Li S, Bluher M, Lin JD. The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis. Nat Med. 2014;20:1436\u201343. https:\/\/doi.org\/10.1038\/nm.3713.","journal-title":"Nat Med"},{"key":"793_CR14","doi-asserted-by":"publisher","first-page":"e0141657","DOI":"10.1371\/journal.pone.0141657","volume":"10","author":"S Akhtar","year":"2015","unstructured":"Akhtar S, Chandrasekhar B, Attur S, Dhaunsi GS, Yousif MH, Benter IF. Transactivation of ErbB Family of Receptor Tyrosine Kinases Is Inhibited by Angiotensin-(1\u20137) via Its Mas Receptor. PLoS One. 2015;10:e0141657. https:\/\/doi.org\/10.1371\/journal.pone.0141657.","journal-title":"PLoS One"},{"key":"793_CR15","first-page":"16520","volume":"8","author":"B Maitusong","year":"2015","unstructured":"Maitusong B, Xie X, Ma YT, Fu ZY, Yang YN, Li XM, Liu F, Chen BD, Gai MT. Association between ErbB3 genetic polymorphisms and coronary artery disease in the Han and Uyghur populations of China. Int J Clin Exp Med. 2015;8:16520\u20137.","journal-title":"Int J Clin Exp Med"},{"key":"793_CR16","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1161\/CIRCULATIONAHA.119.043385","volume":"141","author":"M Ottolini","year":"2020","unstructured":"Ottolini M, Hong K, Cope EL, Daneva Z, DeLalio LJ, Sokolowski JD, Marziano C, Nguyen NY, Altschmied J, Haendeler J, Johnstone SR, Kalani MY, Park MS, Patel RP, Liedtke W, Isakson BE, Sonkusare SK. Local Peroxynitrite Impairs Endothelial Transient Receptor Potential Vanilloid 4 Channels and Elevates Blood Pressure in Obesity. Circulation. 2020;141:1318\u201333. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.043385.","journal-title":"Circulation"},{"key":"793_CR17","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1111\/bph.13072","volume":"172","author":"M Saifeddine","year":"2015","unstructured":"Saifeddine M, El-Daly M, Mihara K, Bunnett NW, McIntyre P, Altier C, Hollenberg MD, Ramachandran R. GPCR-mediated EGF receptor transactivation regulates TRPV4 action in the vasculature. Br J Pharmacol. 2015;172:2493\u2013506. https:\/\/doi.org\/10.1111\/bph.13072.","journal-title":"Br J Pharmacol"},{"key":"793_CR18","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1001\/jama.1996.03530440051036","volume":"275","author":"WB Kannel","year":"1996","unstructured":"Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA. 1996;275:1571\u20136.","journal-title":"JAMA"},{"key":"793_CR19","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1161\/01.cir.67.5.968","volume":"67","author":"HB Hubert","year":"1983","unstructured":"Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67:968\u201377. https:\/\/doi.org\/10.1161\/01.cir.67.5.968.","journal-title":"Circulation"},{"issue":"Suppl B","key":"793_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/eurheartj\/8.suppl_b.57","volume":"8","author":"S MacMahon","year":"1987","unstructured":"MacMahon S, Cutler J, Brittain E, Higgins M. Obesity and hypertension: epidemiological and clinical issues. Eur Heart J. 1987;8(Suppl B):57\u201370. https:\/\/doi.org\/10.1093\/eurheartj\/8.suppl_b.57.","journal-title":"Eur Heart J."},{"key":"793_CR21","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1097\/HJH.0b013e32834937d6","volume":"29","author":"R Matsukawa","year":"2011","unstructured":"Matsukawa R, Hirooka Y, Nishihara M, Ito K, Sunagawa K. Neuregulin-1\/ErbB signaling in rostral ventrolateral medulla is involved in blood pressure regulation as an antihypertensive system. J Hypertens. 2011;29:1735\u201342. https:\/\/doi.org\/10.1097\/HJH.0b013e32834937d6.","journal-title":"J Hypertens"},{"key":"793_CR22","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/0895-7061(95)00216-2","volume":"8","author":"N Wiinberg","year":"1995","unstructured":"Wiinberg N, Hoegholm A, Christensen HR, Bang LE, Mikkelsen KL, Nielsen PE, Svendsen TL, Kampmann JP, Madsen NH, Bentzon MW. 24-h ambulatory blood pressure in 352 normal Danish subjects, related to age and gender. Am J Hypertens. 1995;8:978\u201386. https:\/\/doi.org\/10.1016\/0895-7061(95)00216-2.","journal-title":"Am J Hypertens"},{"key":"793_CR23","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ijcard.2014.12.071","volume":"181","author":"I Shiue","year":"2015","unstructured":"Shiue I. Self and environmental exposures to drinking, smoking, gambling or video game addiction are associated with adult hypertension, heart and cerebrovascular diseases, allergy, self-rated health and happiness: Japanese General Social Survey, 2010. Int J Cardiol. 2015;181:403\u201312. https:\/\/doi.org\/10.1016\/j.ijcard.2014.12.071.","journal-title":"Int J Cardiol"},{"key":"793_CR24","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1097\/HJH.0000000000000522","volume":"33","author":"SM Attard","year":"2015","unstructured":"Attard SM, Herring AH, Zhang B, Du S, Popkin BM, Gordon-Larsen P. Associations between age, cohort, and urbanization with SBP and DBP in China: a population-based study across 18 years. J Hypertens. 2015;33:948\u201356. https:\/\/doi.org\/10.1097\/HJH.0000000000000522.","journal-title":"J Hypertens"},{"key":"793_CR25","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1161\/01.cir.81.5.1498","volume":"81","author":"DS Freedman","year":"1990","unstructured":"Freedman DS, Jacobsen SJ, Barboriak JJ, Sobocinski KA, Anderson AJ, Kissebah AH, Sasse EA, Gruchow HW. Body fat distribution and male\/female differences in lipids and lipoproteins. Circulation. 1990;81:1498\u2013506. https:\/\/doi.org\/10.1161\/01.cir.81.5.1498.","journal-title":"Circulation"},{"key":"793_CR26","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1101\/gr.333502","volume":"12","author":"LA Cox","year":"2002","unstructured":"Cox LA, Birnbaum S, VandeBerg JL. Identification of candidate genes regulating HDL cholesterol using a chromosomal region expression array. Genome Res. 2002;12:1693\u2013702. https:\/\/doi.org\/10.1101\/gr.333502.","journal-title":"Genome Res"},{"key":"793_CR27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1161\/HYPERTENSIONAHA.114.00920","volume":"64","author":"K Rahmouni","year":"2014","unstructured":"Rahmouni K. Obesity-associated hypertension: recent progress in deciphering the pathogenesis. Hypertension. 2014;64:215\u201321. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.114.00920.","journal-title":"Hypertension"},{"key":"793_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1017\/S0007114516001744","volume":"116","author":"ZY Zou","year":"2016","unstructured":"Zou ZY, Yang YD, Wang S, Dong B, Li XH, Ma J. The importance of blood lipids in the association between BMI and blood pressure among Chinese overweight and obese children. Br J Nutr. 2016;116:45\u201351. https:\/\/doi.org\/10.1017\/S0007114516001744.","journal-title":"Br J Nutr"},{"key":"793_CR29","doi-asserted-by":"publisher","unstructured":"Rahman A, Henry KM, Herman KD, Thompson AA, Isles HM, Tulotta C, Sammut D, Rougeot JJ, Khoshaein N, Reese AE, Higgins K, Tabor C, Sabroe I, Zuercher WJ, Savage CO, Meijer AH, Whyte MK, Dockrell DH, Renshaw SA, Prince LR. Inhibition of ErbB kinase signalling promotes resolution of neutrophilic inflammation. Elife. 2019;8. https:\/\/doi.org\/10.7554\/eLife.50990.","DOI":"10.7554\/eLife.50990"},{"key":"793_CR30","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s10911-008-9107-3","volume":"13","author":"Q Jin","year":"2008","unstructured":"Jin Q, Esteva FJ. Cross-talk between the ErbB\/HER family and the type I insulin-like growth factor receptor signaling pathway in breast cancer. J Mammary Gland Biol Neoplasia. 2008;13:485\u201398. https:\/\/doi.org\/10.1007\/s10911-008-9107-3.","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"793_CR31","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/ajh\/hpx195","volume":"31","author":"Y Yao","year":"2018","unstructured":"Yao Y, Zhu L, Fang Z, Yang S, Chen Y, Jin Y, Zhao X, Zhao H, Zhuang Q, Chen X, Shen C. Insulin-Like Growth Factor-1 and Receptor Contribute Genetic Susceptibility to Hypertension in a Han Chinese Population. Am J Hypertens. 2018;31:422\u201330. https:\/\/doi.org\/10.1093\/ajh\/hpx195.","journal-title":"Am J Hypertens"},{"key":"793_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ghir.2017.11.001","volume":"39","author":"RC Ricco","year":"2018","unstructured":"Ricco RC, Ricco RG, Queluz MC, de Paula MTS, Atique PV, Custodio RJ, Tourinho Filho H, Del Roio Liberatori R Jr, Martinelli CE Jr. IGF-1R mRNA expression is increased in obese children. Growth Horm IGF Res. 2018;39:1\u20135. https:\/\/doi.org\/10.1016\/j.ghir.2017.11.001.","journal-title":"Growth Horm IGF Res"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-021-00793-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-021-00793-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-021-00793-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T13:02:54Z","timestamp":1624798974000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-021-00793-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,27]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["793"],"URL":"https:\/\/doi.org\/10.1186\/s12902-021-00793-8","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,27]]},"assertion":[{"value":"17 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the First Affiliated Yijishan Hospital of Wannan Medical College (Wuhu,China).Written informed consent was obtained from each participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"130"}}